FOOD AND DRUG ADMINISTRATION

CENTER FOR BIOLOGICAL EVALUATION AND RESEARCH

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

VRBPAC

Draft Committee Discussion Question

March 17, 2004

Open Session

1. Does the committee confirm its recommendation made on February 19, 2004 to change the influenza B component to a B/Shanghai/361/2002 - like strain of B/Yamagata/16/88 hemagglutinin lineage for vaccines to be used during the 2004 - 2005 season?